Introduction
============

The discovery of penicillin was crucial to the cure of syphilis. However, the increase of syphilitic sero-resistance in recent years has led to the cure of syphilis facing new challenges. Early-stage syphilis patients undergoing regular treatment and whose serum rapid plasma reagin (RPR) test titer is not negatively conversed within 2 years indicate a condition of sero-resistance (with elimination of neurosyphilis) ([@b1-etm-0-0-3178]). Once sero-resistance occurs, an increase in the dose of penicillin and prolonging the course of treatment cannot usually make serum converse negatively. Due to the 35% recurrence rate of patients with sero-resistance ([@b1-etm-0-0-3178]), together with the influence of social factors, this phenomenon has become an important clinical and social issue.

Although various theories concerning the formative cause of sero-resistance have been posited, the exact pathogenesis remains unknown. In previously conducted clinical studies on immunologic changes to patients with primary syphilis, secondary syphilis, latent syphilis, as well as patients with sero-resistance syphilis ([@b2-etm-0-0-3178]--[@b4-etm-0-0-3178]), it was identified that in various immunological indicators, CD4^+^CD25^+^ regulatory T (Treg) cells showed more specific changes in patients with sero-resistance and whose proportion of CD4^+^CD25^+^ Treg cells was obviously higher than those in other syphilitic groups ([@b3-etm-0-0-3178]). It has been suggested that Treg cells may play an important role in the process of sero-resistance formation.

The newly identified Treg cells and T helper 17 (Th17) cells have triggered endless relative research. A balance of the two cell types has especially drawn the attention of scholars in recent years. Previous findings showed that the abnormality of Treg/Th17 cellular balance is associated with numerous diseases ([@b5-etm-0-0-3178]). Thus, whether there is any abnormality of Treg/Th17 cellular balance in syphilitic patients with sero-resistance and whether the change of Treg cells identified earlier the result of this change in balance, remains to be considered. The aim of the study was to examine the proportion and correlation of Treg and Th17 cells in syphilic patients with sero-resistance.

Materials and methods
=====================

### Study participants

A total of 49 subjects were enrolled in the study and divided into two groups. The experimental group consisted of 26 sero-resistant syphilitic patients, 16 males and 10 females, aged between 25 and 59 years (mean age, 31.8±8.2 years). The normal control group comprised 23 non-syphilitic healthy donors, 14 males and 9 females, aged between 21 and 40 (mean age, 27.6±5.7 years). The 26 subjects with syphilis were outpatients of The First People\'s Hospital of Xuzhou. Criteria used for patients with sero-resistance were: Patients diagnosed with syphilis, following regular treatment, whose RPR test did not turn negative after continuous follow up of 2 years (reinfection, neurosyphilis and HIV infection were eliminated). The distribution of RPR titers in patients were as follows: 8 cases of 1:1, 7 cases of 1:2, 6 cases of 1:4, 4 cases of 1:8, 1 case of 1:16. The stage of syphilis following the initial treatment was: 1 case of primary syphilis, 4 cases of secondary syphilis, and 21 cases of latent syphilis.

The experimental protocol of the present study was approved by the Hospital\'s Ethics Committee. Participants in the two groups provided written informed consent.

### Equipment

Flow cytometry (PAS model; Sysmex Partec GmbH, Gorlitz, Germany) was applied to determine the proportion of Treg and Th17 cells.

### Antibodies and reagents

Fluorescently-labeled mouse anti-human monoclonal antibody: Anti-CD4-FITC (host/isotype: mouse IgG1, cat. no. 11-0049, clone: RPA-T4, concentration: 5 µl/test); anti-CD25-PerCP-Cy5.5 (host/isotype: mouse IgG1, cat. no.: 12-0259, clone: BC96, concentration: 5 µl/test); anti- Foxp3-PE (host/isotype: rat IgG2a, catalog no.: 12-4776, clone: PCH101, concentration: 5 µl/test); anti-ROR-t-PE (host/isotype: rat IgG2a, cat. no.: 12-6988, clone: AFKJS-9, concentration: 0.2 mg/ml); anti-IL-17-PE (host/isotype: mouse IgG1, cat. no.: 12-7178, clone: eBio64CAP17, concentration: 5 µl/test) and homotypic control antibody with a corresponding fluorescent label were purchased from eBioscience company (San Diego, CA, USA). A QuantiBRITE PE flow quantification kit was purchased from BD Biosciences (San Jose, CA, USA). Foxp3 fixation/permeabilization concentrate and diluent was purchased from eBioscience Company. Phorbol 12-myristate 13-acetate (PMA), Ionomycin and Brefeldin A (BFA), were purchased from Enzo Life Sciences, Inc. (Farmingdale, NY, USA). RPMI-1640 was purchased from Sigma Company (St. Louis, MO, USA).

### Specimen preparation

Density gradient centrifugation was used to isolate peripheral blood mononuclear cells (PBMC) from a 5 ml sample of peripheral blood (with heparin added as an anticoagulant), RPMI-1640 was then used at a concentration of 6×10^6^/ml to perform resuspension as a standby.

Due to the relatively low concentration of the interleukin (IL)-17 molecule in cells, PBMCs were cultured *in vitro* prior to detection of the targeted molecules. The cell suspension (500 µl) with a corresponding amount of PMA, ionomycin and BFA were added at the working concentrations of 25 ng/ml, 1 µg/ml, and 10 µg/ml, respectively. The cells were then incubated for 4 h at 37°C, 5% CO~2~, as a standby.

### Detection of the proportion of Treg cells

Fluorescently-labeled antibodies were used to detect Foxp3 molecules in CD4 and CD25 antigens located at the surface of Treg cells. To this end, uncultured PBMC suspension was added into four test tubes, and in three of these, a corresponding homotypic control antibody was added as a negative control. Anti-CD4-FITC and anti-CD25-PerCP-Cy5.5 antibodies were added into the test tubes and incubated for 20 min, at 4°C, in the dark. The fix/perm reagent was added according to product protocol instruction, followed by 30 min of incubation at 4°C. Following permeabilization, anti-Foxp3-PE antibody was added, and the cell suspension was incubated for 20 min at 4°C, in the dark. After washing the sample, the phosphate-buffered saline suspension was subjected to flow cytometric analysis to determine the proportion of CD4^+^CD25^+^Foxp3^+^ cells in CD4^+^ cells ([Fig. 1](#f1-etm-0-0-3178){ref-type="fig"}).

### Detection for the proportion of Th17 cells

Cultured PBMC suspension was processed in accordance with the flow cytometric testing mentioned earlier, with the cell surface labeled by anti-CD4-FITC antibody. PE-labeled monoclonal IL-17 antibody was added to detect intracellular molecules. The cell suspension was washed and subjected to flow cytometric analysis to determine the proportion of CD4^+^IL-17^+^ cells in CD4^+^ cells ([Fig. 2](#f2-etm-0-0-3178){ref-type="fig"}).

### Quantitative flow cytometry for Foxp3 and ROR-γt cell molecules

The QuantiBRITE PE flow quantitative kit was used under the same flow cytometric conditions as were applied to the samples. The operational procedures were in accordance with the protocol specifications. Quantitative microballoon coated with PE molecules of different concentrations was mixed and detected using flow cytometry. The geometric mean of the fluorescent intensities (GFMI) of the microballoon in each group was obtained. The GFMI and the number of coated PE molecules of different microballoon groups were taken to logarithm to obtain the regression equation ([Fig. 3](#f3-etm-0-0-3178){ref-type="fig"}).

Uncultured PBMC cell suspension, performed using flow cytometry, was initially labeled using CD4-FITC antibody on cell surface. PE-labeled monoclonal antibodies were subsequently used to detect the intracellular molecules of Foxp3 and ROR-γt. ([Fig. 4](#f4-etm-0-0-3178){ref-type="fig"}).

The measured GMFI values of related molecules in single cells underwent the regression equation to identify the corresponding expression quantity of targeted molecules.

A correlation analysis was conducted on the expression data of FoxP3 and ROR-γt molecules in CD4^+^ T cells.

### Statistical analysis

SPSS 11.0 statistical software (SPSS, Inc., Chicago, IL, USA) was used in our data analysis. Since the numerical data did not meet normal distribution, non-parametric tests including the Mann-Whitney U test for data analysis and the Spearman rank test for correlation analysis were employed. P\<0.05 was considered to indicate a statistically significant difference.

Results
=======

### Dection of the proportion of Treg and Th17 cells

Results of the present study detected the proportion of Treg and Th17 cells in peripheral blood of enrolled participants, and determined the quantitative expression of relevant specific transcription factors (Foxp3 and ROR-γt) using flow cytometry ([Figs. 1](#f1-etm-0-0-3178){ref-type="fig"}--[4](#f4-etm-0-0-3178){ref-type="fig"}). The results showed that the proportion of Treg cells in peripheral blood withdrawn from syphilitic patients with sero-resistance was significantly higher than that of the normal control group (p\<0.01), and that the proportion of Th17 cells was significantly lower than that of the normal control group (p\<0.01). Additionally, the expression of transcription factor Foxp3 in CD4^+^ T cells from syphilitic patients with sero-resistance was higher than that in the normal control group, while the expression of ROR-γt was lower in comparison to the normal control (p\<0.05).

### Scattering correlation of the expression between Foxp3 and ROR-γt

Correlation of the expression of Foxp3 and ROR-γt in peripheral blood CD4^+^ T cells had a negative correlation when the samples were taken together (r=−0.481, P\<0.01, [Fig. 5](#f5-etm-0-0-3178){ref-type="fig"}).

Discussion
==========

Treg and Th17 cells are dependent Th cell subsets that are different from Th1 and Th2 cells. Treg cells have immunosuppressive characteristics and may express the specific transcription factor Foxp3 ([@b5-etm-0-0-3178]). Th17 may evoke an inflammatory response through the secretion of IL-17, whose specific transcription factor is ROR-γt. Previous findings have shown that the two play an important role in the occurrence and development of infectious diseases, autoimmune diseases and tumors ([@b5-etm-0-0-3178]). Notably, these two functionally antagonistic cells are derived from the same naïve CD4^+^ T cells under the influence of the same transforming growth factor (TGF)-β cell factor ([@b5-etm-0-0-3178]). TGF-β, when exiting alone, can evoke naïve CD4^+^ T cells to express Foxp3. Since Foxp3 restrains the function of ROR-γt, it promotes the differentiation of Treg cell and restrains the generation of Th17 cells ([@b6-etm-0-0-3178]). However, Bettelli *et al* ([@b7-etm-0-0-3178]) demonstrated that it has been the combined action of TGF-β and IL-6 may be counter-productive, promoting the differentiation of Th17 cells ([@b7-etm-0-0-3178]).

Based on these findings, it has been hypothesized ([@b5-etm-0-0-3178]) that there is a balance between Treg/Th17 cells in the human body, and that the occurrence of certain diseases may be caused by the imbalance of Treg/Th17 cells in the process of naïve CD4^+^ T cell differentiation. This hypothesis replenished the former Th1/Th2 balanced model, and provided a new theoretical basis for some phenomena that could not be explained by the Th1/Th2 model. It was assumed that, by adjusting the balance between Treg and Th17, new treatment strategies could be developed to resume the immune homeostasis. In recent years, some investigators have attempted to examine this method *in vitro*, using animal models and even in human subjects with autoimmune diseases, as well as various proinflammatory cytokine antagonists such as IL-6 and IL-1 antagonists ([@b8-etm-0-0-3178],[@b9-etm-0-0-3178]), IL-2 ([@b10-etm-0-0-3178]), retinoic acid ([@b11-etm-0-0-3178]), interferon ([@b12-etm-0-0-3178]), and environmental toxins ([@b13-etm-0-0-3178]), with a certain degree of efficacy, some of which showed promising results.

The results of the current study showed that the proportion of Treg cells and the expression of Foxp3 in peripheral blood lymphocytes from syphilitic patients with sero-resistance were higher than those from the normal control group, while the proportion of Th17 cells and the expression of ROR-γt were all lower than those of the normal control group. The differences were statistically significant. At the same time, when samples from all the subjects were taken into consideration, the expression of Foxp3 was negatively correlated with the expression of ROR-γt in CD4^+^ T lymphocytes. Based on the present experimental results and the aforementioned Treg/Th17 balance theory, we suggest that Treg and Th17 cells were antagonistic with each other in order to maintain a dynamic equilibrium. Such an equilibrium in syphilitic patients with sero-resistance may offset Treg cells, promoting the differentiation of initial CD4^+^ T cells to Treg cells and restraining the occurrence of Th17 cells, thus leading to cell immunosuppression. In clinical treatment, although a full dose of antibiotics was used, internal treponema pallidums were, due to the cellular immunosuppression of the patients, not cleaned thoroughly, which may stimulate the body to generate antibodies resulting in the development of sero-resistance. This may partly explain the reason for the high recurrence in patients, though the underlying cause for this phenomenon remains to be elucidated. However, whether these patients are congenitally susceptible, or whether it is the long dormant treponema pallidums that lead to the abnormality of the immune system remains to be determined. While some studies indicated a higher proportion of latent syphilis leading to sero-resistance ([@b14-etm-0-0-3178]), additional studies are required to address these issues.

The antibiotic treatment of syphilis is beneficial only with a normally working immune system of the body ([@b15-etm-0-0-3178]). The results showed the presence of abnormality of the immunological state in syphilitic patients with sero-resistance. This finding suggests that in addition to the primary antibiotics treatment, we should also pay close attention to patients\' immunological state in the future clinical management of syphilis, which may lead to the formulation of individualized immunological intervention treatments.

In conclusion, the peripheral blood of syphilitic patients with sero-resistance may have abnormalities in the Treg/Th17 cellular balance, and these abnormalities may be associated with the development of this phenomenon. Potential treatments aiming to adjust the balance between Treg/Th17 may be useful for sero-resistance in syphilitic patients.
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###### 

Proportion of peripheral blood Treg and Th17 cells, and expression of the corresponding transcription factors in patients with sero-resistance and normal controls (mean ± standard deviation).

  Groups            Cases   CD4^+^CD25^+^Foxp3^+^ T cells (%)   CD4^+^IL-17^+^ T cells (%)   Foxp3 expression   ROR-γt expression
  ----------------- ------- ----------------------------------- ---------------------------- ------------------ -------------------
  Sero-resistance   26      33.28±11.84                         3.17±2.32                    2994.86±1099.18    1473.12±752.20
  Normal control    23      22.13±7.79                          8.87±2.00                    2539.72±1086.96    1778.34±388.13
  U-value                   123                                 32                           198                200
  P-value                   \<0.01                              \<0.01                       \<0.05             \<0.05

Treg, regulatory T; Th17, T helper 17; Foxp3, forkhead box P3; ROR-γt, retinoic acid-related orphan receptor γt.
